Ikapharmindo Putramas says IDR 2.07 billion of IPO proceeds remain unspent as of June 30, 2026

• Ikapharmindo Putramas reported IDR 52.41 billion in net IPO proceeds effective Nov. 8, 2023; IDR 50.34 billion had been spent by June 30, 2026.
• Spending skewed to working capital at IDR 43.68 billion, representing 83.34% of net proceeds.
• Capital expenditure for goods, equipment, and machinery reached IDR 6.66 billion, representing 12.71% of net proceeds.
• Remaining funds totaled IDR 2.07 billion, placed at Bank OCBC NISP at a 0% rate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PT Ikapharmindo Putramas Tbk published the original content used to generate this news brief via Indonesia Stock Exchange (IDX) (Ref. ID: 32148905) on September 16, 2026, and is solely responsible for the information contained therein.